Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells

Deficiency in C1q, the recognition component of the classical complement cascade and a pattern recognition receptor involved in apoptotic cell clearance, leads to lupus-like autoimmune diseases characterized by auto-antibodies to self proteins and aberrant innate immune cell activation likely due to...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 188; no. 11; pp. 5682 - 5693
Main Authors Benoit, Marie E, Clarke, Elizabeth V, Morgado, Pedro, Fraser, Deborah A, Tenner, Andrea J
Format Journal Article
LanguageEnglish
Published United States 01.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Deficiency in C1q, the recognition component of the classical complement cascade and a pattern recognition receptor involved in apoptotic cell clearance, leads to lupus-like autoimmune diseases characterized by auto-antibodies to self proteins and aberrant innate immune cell activation likely due to impaired clearance of apoptotic cells. In this study, we developed an autologous system using primary human lymphocytes and human monocyte-derived macrophages (HMDMs) to characterize the effect of C1q on macrophage gene expression profiles during the uptake of apoptotic cells. C1q bound to autologous apoptotic lymphocytes modulated expression of genes associated with JAK/STAT signaling, chemotaxis, immunoregulation, and NLRP3 inflammasome activation in LPS-stimulated HMDMs. Specifically, C1q sequentially induced type I IFNs, IL-27, and IL-10 in LPS-stimulated HMDMs and IL-27 in HMDMs when incubated with apoptotic lymphocyte conditioned media. Coincubation with C1q tails prevented the induction of type I IFNs and IL-27 in a dose-dependent manner, and neutralization of type I IFNs partially prevented IL-27 induction by C1q. Finally, C1q decreased procaspase-1 cleavage and caspase-1-dependent cleavage of IL-1β suggesting a potent inhibitory effect of C1q on inflammasome activation. These results identify specific molecular pathways induced by C1q to suppress macrophage inflammation and provide potential therapeutic targets to control macrophage polarization and thus inflammation and autoimmunity.
AbstractList Deficiency in C1q, the recognition component of the classical complement cascade and a pattern recognition receptor involved in apoptotic cell clearance, leads to lupus-like auto-immune diseases characterized by auto-antibodies to self proteins and aberrant innate immune cell activation likely due to impaired clearance of apoptotic cells. Here, we developed an autologous system using primary human lymphocytes and monocyte-derived macrophages (HMDMs) to characterize the effect of C1q on macrophage gene expression profiles during the uptake of apoptotic cells. C1q bound to autologous apoptotic lymphocytes modulated expression of genes associated with JAK/STAT signaling, chemotaxis, immunoregulation and NLRP3 inflammasome activation in LPS-stimulated HMDMs. Specifically, C1q sequentially induced type I interferons (IFNs), IL-27 and IL-10 in LPS-stimulated HMDMs and IL-27 in HMDMs when incubated with AL conditioned media. Co-incubation with C1q tails prevented the induction of type I IFNs and IL-27 in a dose dependent manner and neutralization of type I IFNs partially prevented IL-27 induction by C1q. Finally, C1q decreased procaspase-1 cleavage and caspase-1 dependent cleavage of IL-1β suggesting potent inhibitory effect of C1q on inflammasome activation. These results identify specific molecular pathways induced by C1q to suppress macrophage inflammation providing potential therapeutic targets to control macrophage polarization, and thus inflammation and autoimmunity.
Deficiency in C1q, the recognition component of the classical complement cascade and a pattern recognition receptor involved in apoptotic cell clearance, leads to lupus-like autoimmune diseases characterized by auto-antibodies to self proteins and aberrant innate immune cell activation likely due to impaired clearance of apoptotic cells. In this study, we developed an autologous system using primary human lymphocytes and human monocyte-derived macrophages (HMDMs) to characterize the effect of C1q on macrophage gene expression profiles during the uptake of apoptotic cells. C1q bound to autologous apoptotic lymphocytes modulated expression of genes associated with JAK/STAT signaling, chemotaxis, immunoregulation, and NLRP3 inflammasome activation in LPS-stimulated HMDMs. Specifically, C1q sequentially induced type I IFNs, IL-27, and IL-10 in LPS-stimulated HMDMs and IL-27 in HMDMs when incubated with apoptotic lymphocyte conditioned media. Coincubation with C1q tails prevented the induction of type I IFNs and IL-27 in a dose-dependent manner, and neutralization of type I IFNs partially prevented IL-27 induction by C1q. Finally, C1q decreased procaspase-1 cleavage and caspase-1-dependent cleavage of IL-1 beta suggesting a potent inhibitory effect of C1q on inflammasome activation. These results identify specific molecular pathways induced by C1q to suppress macrophage inflammation and provide potential therapeutic targets to control macrophage polarization and thus inflammation and autoimmunity.
Deficiency in C1q, the recognition component of the classical complement cascade and a pattern recognition receptor involved in apoptotic cell clearance, leads to lupus-like autoimmune diseases characterized by auto-antibodies to self proteins and aberrant innate immune cell activation likely due to impaired clearance of apoptotic cells. In this study, we developed an autologous system using primary human lymphocytes and human monocyte-derived macrophages (HMDMs) to characterize the effect of C1q on macrophage gene expression profiles during the uptake of apoptotic cells. C1q bound to autologous apoptotic lymphocytes modulated expression of genes associated with JAK/STAT signaling, chemotaxis, immunoregulation, and NLRP3 inflammasome activation in LPS-stimulated HMDMs. Specifically, C1q sequentially induced type I IFNs, IL-27, and IL-10 in LPS-stimulated HMDMs and IL-27 in HMDMs when incubated with apoptotic lymphocyte conditioned media. Coincubation with C1q tails prevented the induction of type I IFNs and IL-27 in a dose-dependent manner, and neutralization of type I IFNs partially prevented IL-27 induction by C1q. Finally, C1q decreased procaspase-1 cleavage and caspase-1-dependent cleavage of IL-1β suggesting a potent inhibitory effect of C1q on inflammasome activation. These results identify specific molecular pathways induced by C1q to suppress macrophage inflammation and provide potential therapeutic targets to control macrophage polarization and thus inflammation and autoimmunity.
Author Morgado, Pedro
Benoit, Marie E
Clarke, Elizabeth V
Tenner, Andrea J
Fraser, Deborah A
Author_xml – sequence: 1
  givenname: Marie E
  surname: Benoit
  fullname: Benoit, Marie E
  organization: Department of Molecular Biology and Biochemistry, Institute for Immunology, University of California, Irvine, Irvine, CA 92697, USA
– sequence: 2
  givenname: Elizabeth V
  surname: Clarke
  fullname: Clarke, Elizabeth V
– sequence: 3
  givenname: Pedro
  surname: Morgado
  fullname: Morgado, Pedro
– sequence: 4
  givenname: Deborah A
  surname: Fraser
  fullname: Fraser, Deborah A
– sequence: 5
  givenname: Andrea J
  surname: Tenner
  fullname: Tenner, Andrea J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22523386$$D View this record in MEDLINE/PubMed
BookMark eNqNkr1vFDEQxS2UiFw-eirkkmaDx1-71yChEyRIkWhIbU283juHtb2xvZES8cezUS4RVCAXU_g3T_Nm3jE5iCk6Qt4BO5dMrj_e-hDmmMZzACZazd6QFSjFGq2ZPiArxjhvoNXtETku5ZYxphmXb8kR54oL0ekV-bVJYRpdcLHSKafqfKQbuKO9z87WQgPanKYdbh2d0ojZP2L1KVKMPR198Avi4zBiCFhScBRt9fe-PtB-zj5uad05Ok8VfzqaBopTmmqq3lLrxrGcksMBx-LO9vWEXH_98mNz2Vx9v_i2-XzVWMW72oDW_MYOzgoBnHfcirYTqtXKDsqCA7YGkIjcSemglT1qsBxky0CuGaISJ-TTs-403wTX28VsxtFM2QfMDyahN3__RL8z23RvhFCdkutF4MNeIKe72ZVqgi9PFjC6NBezLB308kD8G2WcdVJorf8DBcVlpwRfUPaMLtcoJbvhdXhg5ikK5iUKZh-FpeX9n6ZfG15uL34Dsui1Vg
CitedBy_id crossref_primary_10_1016_j_jaci_2013_06_006
crossref_primary_10_1128_MMBR_00177_20
crossref_primary_10_1146_annurev_immunol_110519_071134
crossref_primary_10_1093_ofid_ofad151
crossref_primary_10_1111_aji_12586
crossref_primary_10_5483_BMBRep_2022_55_10_115
crossref_primary_10_1016_j_coi_2012_08_004
crossref_primary_10_3389_fimmu_2016_00230
crossref_primary_10_1212_NXI_0000000000200270
crossref_primary_10_3389_fonc_2021_769727
crossref_primary_10_1002_art_39781
crossref_primary_10_1155_2013_348092
crossref_primary_10_1182_blood_2016_05_719757
crossref_primary_10_3389_fimmu_2018_02430
crossref_primary_10_2139_ssrn_3976482
crossref_primary_10_1002_JLB_3MIR0220_270R
crossref_primary_10_3389_fimmu_2023_1148061
crossref_primary_10_1016_j_jbc_2023_105566
crossref_primary_10_1111_imr_12462
crossref_primary_10_1111_imr_12221
crossref_primary_10_1371_journal_pone_0092340
crossref_primary_10_1016_j_ebiom_2023_104452
crossref_primary_10_1111_aji_12357
crossref_primary_10_1016_j_molimm_2017_05_025
crossref_primary_10_1016_j_imbio_2023_152337
crossref_primary_10_1038_s41581_023_00704_1
crossref_primary_10_1186_1742_2094_11_23
crossref_primary_10_3389_fimmu_2021_712936
crossref_primary_10_1002_eji_201546131
crossref_primary_10_1189_jlb_3A0614_278R
crossref_primary_10_1016_j_addr_2020_04_012
crossref_primary_10_1189_jlb_3MR0214_109R
crossref_primary_10_1177_0961203321992434
crossref_primary_10_1038_s41588_020_0636_z
crossref_primary_10_3390_biom13010185
crossref_primary_10_1016_j_clim_2016_09_005
crossref_primary_10_2217_imt_13_103
crossref_primary_10_4049_jimmunol_1700245
crossref_primary_10_3389_fimmu_2019_02887
crossref_primary_10_1084_jem_20201353
crossref_primary_10_1111_imm_12556
crossref_primary_10_4049_jimmunol_1601445
crossref_primary_10_1016_j_jcmgh_2020_05_002
crossref_primary_10_1158_2326_6066_CIR_18_0891
crossref_primary_10_1016_j_ddmod_2014_05_006
crossref_primary_10_1016_j_micpath_2019_04_017
crossref_primary_10_3389_fimmu_2020_00506
crossref_primary_10_1016_j_expneurol_2014_04_028
crossref_primary_10_1016_j_clim_2019_06_009
crossref_primary_10_3390_ijms242216515
crossref_primary_10_1186_s41232_023_00301_6
crossref_primary_10_3390_ijms222413493
crossref_primary_10_3389_fimmu_2018_00959
crossref_primary_10_2139_ssrn_4122922
crossref_primary_10_3389_fimmu_2019_00774
crossref_primary_10_1038_nri3761
crossref_primary_10_3389_fimmu_2019_02712
crossref_primary_10_1073_pnas_1212753109
crossref_primary_10_1159_000358834
crossref_primary_10_1016_j_imbio_2015_05_001
crossref_primary_10_1038_nrrheum_2016_136
crossref_primary_10_1038_s41598_022_20232_5
crossref_primary_10_2147_ITT_S305420
crossref_primary_10_3389_fimmu_2017_00545
crossref_primary_10_1002_dneu_22905
crossref_primary_10_1016_j_dci_2018_05_023
crossref_primary_10_1016_j_heliyon_2023_e15224
crossref_primary_10_1016_j_smim_2018_02_003
crossref_primary_10_3390_ijms17081281
crossref_primary_10_3389_fimmu_2022_1021413
crossref_primary_10_3390_biomedicines8100398
crossref_primary_10_1371_journal_pgen_1008180
crossref_primary_10_1136_annrheumdis_2014_205287
crossref_primary_10_1002_JLB_3MIR0919_191R
crossref_primary_10_4049_jimmunol_1501659
crossref_primary_10_1016_j_trecan_2022_02_006
crossref_primary_10_1189_jlb_4RI1014_521R
crossref_primary_10_1016_j_molimm_2019_06_007
crossref_primary_10_1146_annurev_immunol_042617_053245
crossref_primary_10_26508_lsa_202000935
crossref_primary_10_3389_fcell_2021_657472
crossref_primary_10_1038_ni_3858
crossref_primary_10_3389_fonc_2021_732743
crossref_primary_10_1007_s12026_013_8422_y
crossref_primary_10_1016_j_molimm_2019_10_008
crossref_primary_10_3389_fimmu_2022_842451
crossref_primary_10_1007_s00011_014_0762_0
crossref_primary_10_3390_antiox10111666
crossref_primary_10_1038_mi_2016_87
crossref_primary_10_1016_j_cyto_2021_155522
crossref_primary_10_1016_j_biomaterials_2016_04_033
crossref_primary_10_1016_j_cellsig_2013_11_004
crossref_primary_10_18705_2782_3806_2022_2_2_63_71
crossref_primary_10_1016_j_scr_2014_06_004
crossref_primary_10_3390_cells10092288
crossref_primary_10_1038_cti_2016_90
crossref_primary_10_1016_j_atherosclerosis_2016_08_019
crossref_primary_10_1016_j_compbiomed_2023_106836
crossref_primary_10_1038_s41398_022_01794_4
crossref_primary_10_1016_j_molimm_2021_10_010
crossref_primary_10_4049_jimmunol_1401009
crossref_primary_10_1038_s41598_020_63041_4
crossref_primary_10_1186_s13287_022_03174_7
crossref_primary_10_1089_wound_2023_0149
crossref_primary_10_1111_cpr_13022
crossref_primary_10_1371_journal_pgen_1011176
crossref_primary_10_1097_BOR_0000000000000088
crossref_primary_10_1038_s41435_018_0020_5
crossref_primary_10_1097_BOR_0000000000000083
crossref_primary_10_1186_s40478_022_01416_6
crossref_primary_10_1111_imr_12382
crossref_primary_10_3390_ijms22168934
crossref_primary_10_1007_s00251_019_01103_2
crossref_primary_10_1042_BSR20222267
crossref_primary_10_12688_f1000research_6075_2
crossref_primary_10_12688_f1000research_6075_1
crossref_primary_10_1016_j_ijbiomac_2024_131863
crossref_primary_10_1038_s41467_020_16164_1
crossref_primary_10_1080_19768354_2023_2264354
crossref_primary_10_3389_fimmu_2014_00402
crossref_primary_10_1155_2019_2923072
crossref_primary_10_1038_s41423_021_00751_3
crossref_primary_10_1016_j_isci_2021_103347
crossref_primary_10_1111_imr_12537
crossref_primary_10_1021_acsabm_1c00461
crossref_primary_10_1038_s41598_017_17318_w
crossref_primary_10_2147_COPD_S388297
crossref_primary_10_1016_j_molimm_2013_05_223
crossref_primary_10_1038_s41598_017_00290_w
crossref_primary_10_1016_j_clim_2016_08_010
crossref_primary_10_1523_JNEUROSCI_0555_21_2021
crossref_primary_10_1007_s12016_020_08825_2
crossref_primary_10_1186_s12950_015_0098_8
crossref_primary_10_3389_fimmu_2023_1296580
crossref_primary_10_1080_14728222_2023_2177532
crossref_primary_10_1186_s12974_017_0814_9
crossref_primary_10_1016_j_cellimm_2020_104088
crossref_primary_10_3389_fneur_2018_01062
crossref_primary_10_1146_annurev_immunol_101921_035639
crossref_primary_10_1016_j_bcp_2017_10_001
crossref_primary_10_3389_fimmu_2014_00312
crossref_primary_10_1016_j_cca_2016_12_017
crossref_primary_10_1038_s12276_022_00774_4
crossref_primary_10_1172_jci_insight_124317
crossref_primary_10_37349_ei_2022_00072
crossref_primary_10_1111_ctr_13765
crossref_primary_10_1016_j_expneurol_2024_114877
crossref_primary_10_1021_acsami_1c02542
crossref_primary_10_1007_s12016_013_8386_7
crossref_primary_10_1016_j_smim_2018_01_003
crossref_primary_10_3389_fimmu_2017_01034
crossref_primary_10_37349_ei_2023_00122
crossref_primary_10_1016_j_jcmgh_2018_01_012
crossref_primary_10_1186_s12935_019_1027_3
crossref_primary_10_3389_fimmu_2022_918551
crossref_primary_10_1007_s12026_015_8705_6
crossref_primary_10_1038_cti_2017_50
crossref_primary_10_3389_fimmu_2023_1196544
crossref_primary_10_1155_2016_1340156
crossref_primary_10_3389_fimmu_2017_00636
crossref_primary_10_1038_nrneph_2016_70
crossref_primary_10_4049_jimmunol_1900692
crossref_primary_10_1080_14728222_2018_1439924
crossref_primary_10_3389_fimmu_2015_00257
crossref_primary_10_1002_cti2_1279
crossref_primary_10_1074_jbc_M112_400168
crossref_primary_10_4049_jimmunol_1202388
crossref_primary_10_1016_j_phrs_2022_106309
crossref_primary_10_3389_fonc_2022_812663
crossref_primary_10_1038_s41419_019_2065_4
crossref_primary_10_1073_pnas_1318309110
crossref_primary_10_4196_kjpp_2018_22_1_1
crossref_primary_10_1080_08830185_2019_1609962
crossref_primary_10_3389_fcimb_2016_00195
crossref_primary_10_1158_0008_5472_CAN_20_0503
crossref_primary_10_1152_ajpgi_00115_2019
crossref_primary_10_3389_fimmu_2022_994828
crossref_primary_10_1083_jcb_201708002
crossref_primary_10_21769_BioProtoc_877
crossref_primary_10_1016_j_smim_2018_03_003
Cites_doi 10.1111/j.1471-4159.2008.05668.x
10.1016/S1074-7613(00)80356-8
10.1182/blood-2003-09-3046
10.1042/bj20030304
10.4049/jimmunol.179.12.7993
10.1016/0022-510X(94)00269-T
10.4049/jimmunol.158.10.4525
10.4049/jimmunol.0902232
10.1016/S0076-6879(06)11009-5
10.1016/j.ab.2009.09.041
10.4049/jimmunol.169.7.3978
10.1016/S0021-9258(18)54929-2
10.1146/annurev.pathmechdis.3.121806.151456
10.1074/jbc.M502820200
10.1016/j.molimm.2006.06.021
10.1146/annurev.immunol.22.012703.104549
10.1038/nprot.2008.211
10.4049/jimmunol.136.12.4604
10.4049/jimmunol.172.8.4948
10.1002/eji.200324026
10.1038/nprot.2007.324
10.1038/nri2215
10.1111/j.1365-2249.2009.03896.x
10.1084/jem.192.3.359
10.1016/0006-291X(82)91536-4
10.1038/ni.1937
10.1042/bj2330451
10.1016/j.immuni.2011.02.006
10.1042/bj2160385
10.4049/jimmunol.127.2.648
10.4049/jimmunol.172.6.3406
10.4049/jimmunol.0901575
10.1016/j.it.2008.11.003
10.4049/jimmunol.166.5.3231
10.1038/sj.cdd.4402184
10.1016/S0065-2776(01)76021-X
10.4049/jimmunol.1002041
10.1038/nprot.2008.73
10.1038/ng0598-56
10.4049/jimmunol.146.10.3356
10.4049/jimmunol.147.11.3988
10.1046/j.1471-4159.1997.68052046.x
10.4049/jimmunol.173.5.3044
10.1523/JNEUROSCI.3932-10.2011
10.1038/ni.1944
10.4049/jimmunol.1001731
10.1126/science.75568
10.1038/ng1201-365
10.1016/j.molimm.2010.02.006
10.1111/j.1471-4159.2009.06494.x
10.1189/jlb.1105683
10.1002/biot.200800273
10.1084/jem.194.6.781
10.1111/j.1600-065X.2008.00706.x
10.4049/jimmunol.180.11.7613
10.1073/pnas.0801015105
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7T5
H94
5PM
DOI 10.4049/jimmunol.1103760
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 5693
ExternalDocumentID 10_4049_jimmunol_1103760
22523386
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI041090-14
– fundername: NIA NIH HHS
  grantid: P01 AG000538-33
– fundername: NCRR NIH HHS
  grantid: UL1 RR031985
– fundername: NIAID NIH HHS
  grantid: R01 AI041090
– fundername: NIA NIH HHS
  grantid: AG 00538
– fundername: NIA NIH HHS
  grantid: P01 AG000538
– fundername: NCATS NIH HHS
  grantid: UL1 TR000153
– fundername: NCRR NIH HHS
  grantid: UL1 RR031985-02
– fundername: NIAID NIH HHS
  grantid: AI 41090
– fundername: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
  grantid: R01 AI041090-14 || AI
GroupedDBID ---
-~X
.55
18M
1KJ
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
79B
85S
AARDX
ABCQX
ABJNI
ABOCM
ABPPZ
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADNWM
AENEX
AFHIN
AFOSN
AFRAH
AHWXS
AIZAD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CUY
CVF
D0L
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
IH2
K-O
KQ8
L7B
NPM
OK1
P0W
P2P
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TR2
TWZ
W8F
WH7
WOQ
X7M
XJT
XSW
XTH
YHG
5WD
AAYXX
CITATION
OCZFY
7X8
7T5
H94
5PM
AETEA
ID FETCH-LOGICAL-c528t-1662bcfec3312282c37835765cf5c1e109114aa2e44e174da61c214701490aa53
ISSN 0022-1767
IngestDate Tue Sep 17 21:17:01 EDT 2024
Tue Dec 03 23:18:17 EST 2024
Wed Dec 04 08:47:06 EST 2024
Wed Dec 04 09:18:03 EST 2024
Fri Dec 06 03:10:43 EST 2024
Sat Sep 28 07:49:34 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c528t-1662bcfec3312282c37835765cf5c1e109114aa2e44e174da61c214701490aa53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.jimmunol.org/content/jimmunol/188/11/5682.full.pdf
PMID 22523386
PQID 1015248532
PQPubID 23462
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3358549
proquest_miscellaneous_1551616113
proquest_miscellaneous_1020843666
proquest_miscellaneous_1015248532
crossref_primary_10_4049_jimmunol_1103760
pubmed_primary_22523386
PublicationCentury 2000
PublicationDate 2012-06-01
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2012
References 18490764 - J Immunol. 2008 Jun 1;180(11):7613-21
9109531 - J Neurochem. 1997 May;68(5):2046-52
21041726 - J Immunol. 2010 Dec 1;185(11):6599-607
18786171 - J Neurochem. 2008 Dec;107(5):1169-87
20844193 - J Immunol. 2010 Oct 15;185(8):4738-49
75568 - Science. 1978 Mar 10;199(4333):1080-2
21368058 - J Neurosci. 2011 Mar 2;31(9):3459-69
18546601 - Nat Protoc. 2008;3(6):1101-8
16203735 - J Biol Chem. 2005 Dec 2;280(48):39914-24
18039143 - Annu Rev Pathol. 2008;3:99-126
19144569 - Trends Immunol. 2009 Feb;30(2):83-90
7252154 - J Immunol. 1981 Aug;127(2):648-53
19302245 - Clin Exp Immunol. 2009 May;156(2):303-11
11207277 - J Immunol. 2001 Mar 1;166(5):3231-9
19864605 - J Immunol. 2009 Nov 15;183(10):6175-85
10934224 - J Exp Med. 2000 Aug 7;192(3):359-66
17947979 - Nat Protoc. 2007;2(10):2366-82
15067075 - J Immunol. 2004 Apr 15;172(8):4948-55
11560994 - J Exp Med. 2001 Sep 17;194(6):781-95
9144462 - J Immunol. 1997 May 15;158(10):4525-8
18579773 - Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9023-8
6289835 - Biochem Biophys Res Commun. 1982 Jul 30;107(2):618-23
15004139 - J Immunol. 2004 Mar 15;172(6):3406-14
1902854 - J Immunol. 1991 May 15;146(10):3356-64
19841166 - J Immunol. 2009 Nov 15;183(10):6469-77
17571081 - Cell Death Differ. 2008 Feb;15(2):243-50
19161426 - Immunol Rev. 2008 Dec;226:205-18
12656673 - Biochem J. 2003 Jul 1;373(Pt 1):101-13
16939790 - Methods Enzymol. 2006;411:134-93
7544401 - J Neurol Sci. 1995 May;130(1):11-6
20935647 - Nat Immunol. 2010 Nov;11(11):1014-22
19370710 - Biotechnol J. 2009 Aug;4(8):1210-4
18340345 - Nat Rev Immunol. 2008 Apr;8(4):279-89
16908067 - Mol Immunol. 2007 Jan;44(1-3):33-43
14971048 - Eur J Immunol. 2004 Jan;34(1):221-30
20417969 - Mol Immunol. 2010 Jul;47(11-12):2129-37
18056338 - J Immunol. 2007 Dec 15;179(12):7993-8
21349431 - Immunity. 2011 Feb 25;34(2):213-23
9590289 - Nat Genet. 1998 May;19(1):56-9
12244199 - J Immunol. 2002 Oct 1;169(7):3978-86
1939090 - J Biol Chem. 1991 Oct 25;266(30):20345-55
1940381 - J Immunol. 1991 Dec 1;147(11):3988-93
11079100 - Adv Immunol. 2000;76:227-324
20856220 - Nat Immunol. 2010 Oct;11(10):889-96
14726389 - Blood. 2004 May 15;103(10):3813-20
16617157 - J Leukoc Biol. 2006 Jul;80(1):107-16
19788886 - Anal Biochem. 2010 Feb 1;397(1):129-31
6318736 - Biochem J. 1983 Nov 15;216(2):385-92
3485427 - Biochem J. 1986 Jan 15;233(2):451-8
3486907 - J Immunol. 1986 Jun 15;136(12):4604-10
11726920 - Nat Genet. 2001 Dec;29(4):365-71
15032584 - Annu Rev Immunol. 2004;22:431-56
9324355 - Immunity. 1997 Sep;7(3):345-55
15322164 - J Immunol. 2004 Sep 1;173(5):3044-50
19131956 - Nat Protoc. 2009;4(1):44-57
19919576 - J Neurochem. 2010 Feb;112(3):733-43
Xu (2023010206172832700_r7) 2008; 180
Manderson (2023010206172832700_r4) 2004; 22
Iyer (2023010206172832700_r43) 2010; 185
Klickstein (2023010206172832700_r16) 1997; 7
Williams (2023010206172832700_r57) 2005; 280
Castellano (2023010206172832700_r18) 2010; 47
Khoury (2023010206172832700_r39) 2010; 397
Kurowska-Stolarska (2023010206172832700_r49) 2009; 183
Gullstrand (2023010206172832700_r45) 2009; 156
Bohlson (2023010206172832700_r1) 2007; 44
Alexander (2023010206172832700_r3) 2008; 107
Yamada (2023010206172832700_r26) 2004; 34
Taylor (2023010206172832700_r13) 2000; 192
Nauta (2023010206172832700_r5) 2004; 173
Guan (2023010206172832700_r30) 1991; 266
Petry (2023010206172832700_r17) 1991; 147
Korb (2023010206172832700_r10) 1997; 158
Ziccardi (2023010206172832700_r40) 1978; 199
Cline (2023010206172832700_r35) 2007; 2
Fraser (2023010206172832700_r46) 2010; 112
Stehlik (2023010206172832700_r54) 2003; 373
Mosser (2023010206172832700_r51) 2008; 226
Dietzschold (2023010206172832700_r23) 1995; 130
Ogden (2023010206172832700_r11) 2001; 194
Fraser (2023010206172832700_r25) 2006; 80
Norsworthy (2023010206172832700_r27) 2004; 172
Huang (2023010206172832700_r34) 2009; 4
Kemper (2023010206172832700_r6) 2008; 105
Ziccardi (2023010206172832700_r22) 1982; 107
Brazma (2023010206172832700_r36) 2001; 29
Benoit (2023010206172832700_r37) 2011; 31
Navratil (2023010206172832700_r15) 2001; 166
Sjöberg (2023010206172832700_r2) 2009; 30
Fraser (2023010206172832700_r8) 2009; 183
Bobak (2023010206172832700_r32) 1986; 136
Nold (2023010206172832700_r50) 2010; 11
Lionetti (2023010206172832700_r31) 1980
Biswas (2023010206172832700_r48) 2010; 11
Goldsmith (2023010206172832700_r24) 1997; 68
Saeed (2023010206172832700_r33) 2006; 411
Pickering (2023010206172832700_r9) 2000; 76
Botto (2023010206172832700_r14) 1998; 19
Kim (2023010206172832700_r55) 2004; 172
Kono (2023010206172832700_r44) 2008; 8
Tenner (2023010206172832700_r28) 1981; 127
Santer (2023010206172832700_r52) 2010; 185
Guarda (2023010206172832700_r56) 2011; 34
Castellano (2023010206172832700_r20) 2004; 103
Bensa (2023010206172832700_r21) 1983; 216
Stehlik (2023010206172832700_r53) 2007; 179
Tenner (2023010206172832700_r19) 1986; 233
Erwig (2023010206172832700_r47) 2008; 15
Dillon (2023010206172832700_r41) 2009; 4
Young (2023010206172832700_r29) 1991; 146
Rock (2023010206172832700_r42) 2008; 3
Vandivier (2023010206172832700_r12) 2002; 169
Schmittgen (2023010206172832700_r38) 2008; 3
References_xml – volume: 107
  start-page: 1169
  year: 2008
  ident: 2023010206172832700_r3
  article-title: The complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration.
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2008.05668.x
  contributor:
    fullname: Alexander
– volume: 7
  start-page: 345
  year: 1997
  ident: 2023010206172832700_r16
  article-title: Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80356-8
  contributor:
    fullname: Klickstein
– volume: 103
  start-page: 3813
  year: 2004
  ident: 2023010206172832700_r20
  article-title: Maturation of dendritic cells abrogates C1q production in vivo and in vitro.
  publication-title: Blood
  doi: 10.1182/blood-2003-09-3046
  contributor:
    fullname: Castellano
– volume: 373
  start-page: 101
  year: 2003
  ident: 2023010206172832700_r54
  article-title: The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation.
  publication-title: Biochem. J.
  doi: 10.1042/bj20030304
  contributor:
    fullname: Stehlik
– volume: 179
  start-page: 7993
  year: 2007
  ident: 2023010206172832700_r53
  article-title: COPs and POPs: modulators of inflammasome activity.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.179.12.7993
  contributor:
    fullname: Stehlik
– volume: 130
  start-page: 11
  year: 1995
  ident: 2023010206172832700_r23
  article-title: Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis.
  publication-title: J. Neurol. Sci.
  doi: 10.1016/0022-510X(94)00269-T
  contributor:
    fullname: Dietzschold
– volume: 158
  start-page: 4525
  year: 1997
  ident: 2023010206172832700_r10
  article-title: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.158.10.4525
  contributor:
    fullname: Korb
– volume: 183
  start-page: 6175
  year: 2009
  ident: 2023010206172832700_r8
  article-title: C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0902232
  contributor:
    fullname: Fraser
– volume: 411
  start-page: 134
  year: 2006
  ident: 2023010206172832700_r33
  article-title: TM4 microarray software suite.
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(06)11009-5
  contributor:
    fullname: Saeed
– volume: 397
  start-page: 129
  year: 2010
  ident: 2023010206172832700_r39
  article-title: Acquisition of chemiluminescent signals from immunoblots with a digital single-lens reflex camera.
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2009.09.041
  contributor:
    fullname: Khoury
– volume: 169
  start-page: 3978
  year: 2002
  ident: 2023010206172832700_r12
  article-title: Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.169.7.3978
  contributor:
    fullname: Vandivier
– volume: 266
  start-page: 20345
  year: 1991
  ident: 2023010206172832700_r30
  article-title: Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis.
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)54929-2
  contributor:
    fullname: Guan
– volume: 3
  start-page: 99
  year: 2008
  ident: 2023010206172832700_r42
  article-title: The inflammatory response to cell death.
  publication-title: Annu. Rev. Pathol.
  doi: 10.1146/annurev.pathmechdis.3.121806.151456
  contributor:
    fullname: Rock
– volume: 280
  start-page: 39914
  year: 2005
  ident: 2023010206172832700_r57
  article-title: The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M502820200
  contributor:
    fullname: Williams
– volume: 44
  start-page: 33
  year: 2007
  ident: 2023010206172832700_r1
  article-title: Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions.
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2006.06.021
  contributor:
    fullname: Bohlson
– volume: 22
  start-page: 431
  year: 2004
  ident: 2023010206172832700_r4
  article-title: The role of complement in the development of systemic lupus erythematosus.
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.22.012703.104549
  contributor:
    fullname: Manderson
– volume: 4
  start-page: 44
  year: 2009
  ident: 2023010206172832700_r34
  article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.211
  contributor:
    fullname: Huang
– volume: 136
  start-page: 4604
  year: 1986
  ident: 2023010206172832700_r32
  article-title: Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.136.12.4604
  contributor:
    fullname: Bobak
– volume: 172
  start-page: 4948
  year: 2004
  ident: 2023010206172832700_r55
  article-title: Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.8.4948
  contributor:
    fullname: Kim
– volume: 34
  start-page: 221
  year: 2004
  ident: 2023010206172832700_r26
  article-title: Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200324026
  contributor:
    fullname: Yamada
– volume: 2
  start-page: 2366
  year: 2007
  ident: 2023010206172832700_r35
  article-title: Integration of biological networks and gene expression data using Cytoscape.
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2007.324
  contributor:
    fullname: Cline
– volume: 8
  start-page: 279
  year: 2008
  ident: 2023010206172832700_r44
  article-title: How dying cells alert the immune system to danger.
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2215
  contributor:
    fullname: Kono
– volume: 156
  start-page: 303
  year: 2009
  ident: 2023010206172832700_r45
  article-title: Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
  publication-title: Clin. Exp. Immunol.
  doi: 10.1111/j.1365-2249.2009.03896.x
  contributor:
    fullname: Gullstrand
– volume: 192
  start-page: 359
  year: 2000
  ident: 2023010206172832700_r13
  article-title: A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.192.3.359
  contributor:
    fullname: Taylor
– volume: 107
  start-page: 618
  year: 1982
  ident: 2023010206172832700_r22
  article-title: The dissociation properties of native C1.
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/0006-291X(82)91536-4
  contributor:
    fullname: Ziccardi
– volume: 11
  start-page: 889
  year: 2010
  ident: 2023010206172832700_r48
  article-title: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1937
  contributor:
    fullname: Biswas
– volume: 233
  start-page: 451
  year: 1986
  ident: 2023010206172832700_r19
  article-title: Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q.
  publication-title: Biochem. J.
  doi: 10.1042/bj2330451
  contributor:
    fullname: Tenner
– volume: 34
  start-page: 213
  year: 2011
  ident: 2023010206172832700_r56
  article-title: Type I interferon inhibits interleukin-1 production and inflammasome activation.
  publication-title: Immunity
  doi: 10.1016/j.immuni.2011.02.006
  contributor:
    fullname: Guarda
– volume: 216
  start-page: 385
  year: 1983
  ident: 2023010206172832700_r21
  article-title: Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
  publication-title: Biochem. J.
  doi: 10.1042/bj2160385
  contributor:
    fullname: Bensa
– volume: 127
  start-page: 648
  year: 1981
  ident: 2023010206172832700_r28
  article-title: Purification and radiolabeling of human C1q.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.127.2.648
  contributor:
    fullname: Tenner
– volume: 172
  start-page: 3406
  year: 2004
  ident: 2023010206172832700_r27
  article-title: Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.6.3406
  contributor:
    fullname: Norsworthy
– volume: 183
  start-page: 6469
  year: 2009
  ident: 2023010206172832700_r49
  article-title: IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0901575
  contributor:
    fullname: Kurowska-Stolarska
– volume: 30
  start-page: 83
  year: 2009
  ident: 2023010206172832700_r2
  article-title: Complement activation and inhibition: a delicate balance.
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2008.11.003
  contributor:
    fullname: Sjöberg
– volume: 166
  start-page: 3231
  year: 2001
  ident: 2023010206172832700_r15
  article-title: The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.166.5.3231
  contributor:
    fullname: Navratil
– volume-title: Methods of Cell Separation.
  year: 1980
  ident: 2023010206172832700_r31
  contributor:
    fullname: Lionetti
– volume: 15
  start-page: 243
  year: 2008
  ident: 2023010206172832700_r47
  article-title: Clearance of apoptotic cells by phagocytes.
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4402184
  contributor:
    fullname: Erwig
– volume: 76
  start-page: 227
  year: 2000
  ident: 2023010206172832700_r9
  article-title: Systemic lupus erythematosus, complement deficiency, and apoptosis.
  publication-title: Adv. Immunol.
  doi: 10.1016/S0065-2776(01)76021-X
  contributor:
    fullname: Pickering
– volume: 185
  start-page: 6599
  year: 2010
  ident: 2023010206172832700_r43
  article-title: Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1002041
  contributor:
    fullname: Iyer
– volume: 3
  start-page: 1101
  year: 2008
  ident: 2023010206172832700_r38
  article-title: Analyzing real-time PCR data by the comparative C(T) method.
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.73
  contributor:
    fullname: Schmittgen
– volume: 19
  start-page: 56
  year: 1998
  ident: 2023010206172832700_r14
  article-title: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
  publication-title: Nat. Genet.
  doi: 10.1038/ng0598-56
  contributor:
    fullname: Botto
– volume: 146
  start-page: 3356
  year: 1991
  ident: 2023010206172832700_r29
  article-title: Complement subcomponent C1q stimulates Ig production by human B lymphocytes.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.146.10.3356
  contributor:
    fullname: Young
– volume: 147
  start-page: 3988
  year: 1991
  ident: 2023010206172832700_r17
  article-title: Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.147.11.3988
  contributor:
    fullname: Petry
– volume: 68
  start-page: 2046
  year: 1997
  ident: 2023010206172832700_r24
  article-title: Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain.
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1997.68052046.x
  contributor:
    fullname: Goldsmith
– volume: 173
  start-page: 3044
  year: 2004
  ident: 2023010206172832700_r5
  article-title: Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.5.3044
  contributor:
    fullname: Nauta
– volume: 31
  start-page: 3459
  year: 2011
  ident: 2023010206172832700_r37
  article-title: Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3932-10.2011
  contributor:
    fullname: Benoit
– volume: 11
  start-page: 1014
  year: 2010
  ident: 2023010206172832700_r50
  article-title: IL-37 is a fundamental inhibitor of innate immunity.
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1944
  contributor:
    fullname: Nold
– volume: 185
  start-page: 4738
  year: 2010
  ident: 2023010206172832700_r52
  article-title: C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1001731
  contributor:
    fullname: Santer
– volume: 199
  start-page: 1080
  year: 1978
  ident: 2023010206172832700_r40
  article-title: Direct demonstration and quantitation of the first complement component in human serum.
  publication-title: Science
  doi: 10.1126/science.75568
  contributor:
    fullname: Ziccardi
– volume: 29
  start-page: 365
  year: 2001
  ident: 2023010206172832700_r36
  article-title: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.
  publication-title: Nat. Genet.
  doi: 10.1038/ng1201-365
  contributor:
    fullname: Brazma
– volume: 47
  start-page: 2129
  year: 2010
  ident: 2023010206172832700_r18
  article-title: Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis.
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2010.02.006
  contributor:
    fullname: Castellano
– volume: 112
  start-page: 733
  year: 2010
  ident: 2023010206172832700_r46
  article-title: C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2009.06494.x
  contributor:
    fullname: Fraser
– volume: 80
  start-page: 107
  year: 2006
  ident: 2023010206172832700_r25
  article-title: C1q and MBL, components of the innate immune system, influence monocyte cytokine expression.
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1105683
  contributor:
    fullname: Fraser
– volume: 4
  start-page: 1210
  year: 2009
  ident: 2023010206172832700_r41
  article-title: Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum.
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.200800273
  contributor:
    fullname: Dillon
– volume: 194
  start-page: 781
  year: 2001
  ident: 2023010206172832700_r11
  article-title: C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.194.6.781
  contributor:
    fullname: Ogden
– volume: 226
  start-page: 205
  year: 2008
  ident: 2023010206172832700_r51
  article-title: Interleukin-10: new perspectives on an old cytokine.
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2008.00706.x
  contributor:
    fullname: Mosser
– volume: 180
  start-page: 7613
  year: 2008
  ident: 2023010206172832700_r7
  article-title: Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.11.7613
  contributor:
    fullname: Xu
– volume: 105
  start-page: 9023
  year: 2008
  ident: 2023010206172832700_r6
  article-title: The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis.
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0801015105
  contributor:
    fullname: Kemper
SSID ssj0006024
Score 2.532142
Snippet Deficiency in C1q, the recognition component of the classical complement cascade and a pattern recognition receptor involved in apoptotic cell clearance, leads...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 5682
SubjectTerms Apoptosis Regulatory Proteins - physiology
Caspase 1 - metabolism
Caspase Inhibitors
Cell Adhesion - immunology
Cell Polarity - immunology
Cells, Cultured
Chemokines - biosynthesis
Complement C1q - physiology
Cytokines - biosynthesis
Humans
Inflammasomes - antagonists & inhibitors
Inflammasomes - immunology
Interleukin-1beta - metabolism
Lipopolysaccharides - metabolism
Lymphocytes - cytology
Lymphocytes - immunology
Macrophages - cytology
Macrophages - immunology
Macrophages - metabolism
Title Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells
URI https://www.ncbi.nlm.nih.gov/pubmed/22523386
https://search.proquest.com/docview/1015248532
https://search.proquest.com/docview/1020843666
https://search.proquest.com/docview/1551616113
https://pubmed.ncbi.nlm.nih.gov/PMC3358549
Volume 188
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBONWbjISPKAprL7k0sdRNg3Yxksr9S1yXEer2JLSpg8gfgO_mXNiJ3ELmgaqFFWpm7j9vvj42N85h5DXIlOJMPkgyHQkAjnkSZCFMwUPXiw1OLlZbOpsn2fR8UR-mobTXu-Xp1paV9k7_eOvcSX_gyqcA1wxSvYfkG0vCifgPeALR0AYjtfCGB9mK_9GwT_WrdwbsW9uGFthUaFluTivVTnowbqQy3q_oA5sWsHwkAMlLtWqvDR7B9qVknCxi_WcdFGpr8bOV8tFVWJ-15G5uFj5s9ouvsymoMCYE5vb6U29gzbw1hvem6KcN2FCc-NFQrRKoVZq1ilwT7H61Ky0iuLZsmxptwQrvPQGTrc269YxUBDS6K28uAIW2-Ic3dic-CRk3lAbRrZqkTPbYWQrLW6bBAkuEJoE99Mx7AF1QJ35a7b8z76kR5OTk3R8OB3fIDcxsSLWYvjw8XNr2aMBl032eeyp3fbGO-xvX39zmvOH77ItwfXmNON75K6DjB5YZt0nPVPsklu2POn3XXL71AkvHpCfHdWooxoFqlFHNdpRjfpUo0A1aqlGfarRhmrUUo0C1ailGi1z2lKN1lR7SCZHh-PRceAKdwQ65EkVsCjimc6NFoJx8Om1wPXFOAp1HmpmMBctk0pxI6UBj3imIqaxXha66wOlQvGI7BRlYZ4QGuUx55nKwyEbSpVl4IArwTOmwU5ppnWfvG3-53Rh87Ok4NciJmmDSeow6ZNXDRApDKK4M6YKU65XqHMMMbef4Fe14YNECnD3r2iD287wYqJPHluA216B4eRCJPDteAP6tgEmet_8pJif1wnfhQCnXg6fXqNvz8id7uF6Tnaq5dq8gGlzlb2sufwbltjI2Q
link.rule.ids 230,314,780,784,885,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Complement+Protein+C1q+Directs+Macrophage+Polarization+and+Limits+Inflammasome+Activity+during+the+Uptake+of+Apoptotic+Cells&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Benoit%2C+Marie+E&rft.au=Clarke%2C+Elizabeth+V&rft.au=Morgado%2C+Pedro&rft.au=Fraser%2C+Deborah+A&rft.date=2012-06-01&rft.issn=0022-1767&rft.volume=188&rft.issue=11&rft.spage=5682&rft.epage=5693&rft_id=info:doi/10.4049%2Fjimmunol.1103760&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon